July 22, 2024
Welcome to our Investor Newsletter edition for the first half of 2024. This Newsletter will present an update on the investment activity of the Wesley Clover Global Ecosystem of Technology companies as well as updates on the expansion of New Funds, LP participation opportunities of the Alacrity Global program and what trends we are watching in technology, investment, and policy.
How to Use AI Customer Support: 8 Strategies
StealC & Vidar Malware Campaign Identified
Executive Health Program: Prioritizing Individual Well-being
The tech vertical of note was AI.
For more information on the featured startup find the links below for further details:
Content for global investor, entrepreneur, and partner audiences.
Wesley Clover issues updates on the portfolio each Quarter on Technology,
Hospitality and Real Estate business.
Find information related to Alacrity Funds, Hubs, and Companies.
Over the next 12 months we are anticipating further Early-Stage Investment attraction specifically in IoT, HealthCare IT, Productivity/Management Software, HRTech, and Security & Monitoring. Companies continue to grow and are looking to accelerate further global growth in the second half of 2024. We have 3 companies looking to raise funds over the next 12 months. Find the investment profile details below:
Website: celestrahealth.com
Industry/Vertical: Healthcare / Digital Health
Location: Ottawa, Canada
Investment Timeline: 2024-2025
Active Users: 90+ (Phase II clinical trial in US, UK and Canada)
Funding Target: Seed, $3 Million
Targets: Angels, VCs
Celestra Health Systems is a health tech company revolutionizing MS treatment using cutting-edge wearable tech, AI, and smartphone apps. Selected for the prestigious UK NHS Digital Health Partnership Award, their solution discreetly monitors key disease indicators, allowing for informed treatment decisions and rapid therapy assessment. With renowned neurologists on their team and Phase II trials underway, Celestra Health has pending patent applications and is engaged with the US FDA for Class II Software as a Medical Device certification.
Current Investors: Wesley Clover International, Debt
Strategic Customers: Global pharmaceutical firms, UK National Health Service (NHS), US Neurology and Rehabilitation clinics specializing in MS.
Website: https://cliniconex.com/
Industry/Vertical: Healthcare Technology, Ambulatory & Long-Term Care.
Location: North America
Investment Timeline: 2024-2026
Estimated ARR CAD: $6.5 Million
Funding Target: Series A, $10 Million
Targets: VC and Corporate Venture
Cliniconex automates patient engagement as the leading communication and collaboration solution for more than 3,000 senior care facilities and 5,000 medical providers, returning 1 million hours to direct care every year. Our solutions reach audiences via voice, text or email, strengthening teams with a record of all conversations, and uniting family-centered communities through timely, transparent outreach. The result? More time to care.
Digital transformation in health care is growing rapidly with national health spending projected to reach $6.2 trillion by 2028 in the U.S alone. Cliniconex seeks capital to accelerate expansion within existing strategic partnerships and into adjacent senior care segments in new markets through product extension.
Current Investors: Angels and Strategic Investors.
Strategic Partners/Customers: PointClickCare, Loblaws, Telus Health
Website: https://teldio.com/
Industry/Vertical: B2B SaaS, Enterprise Workflow Automation and Communication
Location: North America
Investment Timeline: Q4 2024
Estimated ARR CAD: $4 Million+
Funding Target: Series A, $3 Million+
Investor Targets: VC and Corporate Venture
Teldio is a leading provider of advanced communication and fleet tracking solutions designed to enhance safety, communication, and operational efficiency. Teldio offers solutions which extend the value of private two-way radio and video networks and integrate and automate use cases with two-way radios, video management systems and access control systems. Teldio’s mission is to enable safer people, places and things.
With over 1,000+ deployments, Teldio delivers solutions to some of the largest customers across many verticals, with a main focus in manufacturing, utilities, healthcare, transportation and education.
Teldio has grown steadily from 2021 to 2023 and is accelerating in 2024 based on a distribution agreement with Motorola Solutions. The plan is to utilize funding to accelerate organic growthand enable expansion outside of North and South America.
Current Investors: VC, Corporate, Angel
Strategic Customers: Amazon, Tesla, SpaceX, Pfizer, Marriott, P&G, 3M, GE, Nissan, Cargill, Tyson Foods, NYSE, Honda
Alacrity Canada runs programs in support of early-stage technology companies. To-date these programs have supported the development of companies with value greater than $700M. Given the success of the Alacrity program the Emend Vision Fund is being developed with the intent to invest in high potential early-stage companies with strong environmental and sustainability impact. The fund will focus on emerging opportunities through Industrial Transformation, Big Data and Critical Infrastructure, Clean Water and Food Security. For more information contact the Emend Fund on how you can support.
Alacrité France is supporting the development of 10 active NewCos to-date, each having received startup funding of €250K+. Alacrité has now reached a first level of maturity: there are no short-term plans to incorporate new companies, but to focus on the growth of these 10 startups. Several of these newco’s are preparing fundraisings for 2024 and early 2025
The L-SPARK portfolio to-date has had 8 companies exit with a cumulative exit value over $200 Million USD.
Alacrity Mexico continues to support the development of 3 portfolio companies in the Enterprise Contract Lifecycle Management Software (CLMS), Fintech, and Cybersecurity sectors.
Alacrity Turkey is launching its second fund, a $30M USD seed-stage “SaaS Globalization” Venture Fund to invest in Turkish B2B SaaS start-ups.
Alacrity UK continues to support startup ecosystem through programmes to include:
The current Alacrity portfolio has grown to 17 active NewCos. The Cyber Security Program launched in 2020 has now graduated 4 NewCos.
Wesley Clover undertaking exploration of a new fund in the ASEAN region. Early-Stage Venture Builder model for SAAS technology 5 ++2 years, targeted fund size of $10 Million USD.
Wesley Clover undertaking exploration of new fund in the New Delhi. Early-Stage Venture builder in Alacrity India model for SAAS technology 5 ++2 years, targeted fund size of $10 Million USD.
Wesley Clover undertaking exploration of a new fund in South America. Early-Stage Venture Builder model for SAAS technology 5 ++2 years, targeted fund size of $10 Million USD.
Wesley Clover undertaking exploration of a new fund in the UAE. Early-Stage Venture Builder model for SAAS technology 5 ++2 years, targeted fund size of $10 Million USD.
For more information contact Joshua Seerattan via email.
For any Investment related enquiries on portfolio companies, Alacrity Funds or for a Wesley Clover Briefing please contact Joshua Seerattan.
Wesley Clover International is a private, global investment management firm and holding company with over a Billion Dollars of Assets Under Management in Real-Estate & Technology. The focus is to fund and grow successful technology companies. More than 100 firms have been created to-date by Wesley Clover with more than $1.0B in direct investment. The portfolio regularly has more than 40 investments under active management around the globe. All are committed to next-generation Cloud and SaaS applications for fixed and mobile communications, video analytics, security, customer engagement, business enablement and more. Deal flow includes companies within the Enterprise Accelerator, L-SPARK, as well as the Alacrity Global Ecosystem of technology partnership funds which have been deployed in 6 international regions.